(Q41017874)

25 September 2017

Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma (English)

1 reference

25 September 2017

6

1 reference

25 September 2017

Jiyoung Ahn

2

0 references

William B Isaacs

7

object named as

William B Isaacs

1 reference

25 September 2017

1

Adam S Kibel

1 reference

25 September 2017

Masis Isikbay

3

1 reference

25 September 2017

Aleksandra Klim

4

1 reference

25 September 2017

William S Wu

5

1 reference

25 September 2017

E Warwick Daw

8

1 reference

25 September 2017

28 December 2015

1 reference

25 September 2017

1 reference

25 September 2017

76

1 reference

25 September 2017

5

1 reference

25 September 2017

479-490

1 reference

25 September 2017

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Active surveillance for early-stage prostate cancer: review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Castration-resistant prostate cancer: AUA guideline amendment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Genetic background is an important determinant of metastatic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A systems biology approach to defining metastatic biomarkers and signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Chromosome 8q24 markers: risk of early-onset and familial prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Sequence variants at 22q13 are associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Genome-wide association study of prostate cancer-specific survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cell cycle checkpoints: preventing an identity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

CDK4/6 inhibitors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

New directions for drug-resistant breast cancer: the CDK4/6 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

p53 polymorphic variants at codon 72 exert different effects on cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Functional promoter SNPs in cell cycle checkpoint genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Highly parallel SNP genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

TFIIH is negatively regulated by cdk8-containing mediator complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin C/cdk3 promotes Rb-dependent G0 exit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Stress-Induced CDK5 Activation Disrupts Axonal Transport via Lis1/Ndel1/Dynein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

The negative role of cyclin G in ATM-dependent p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Structure, expression, and chromosomal localization of human GAK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Regulation of the p53 response and its relationship to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Association between MDM2 SNP309 and skin cancer: A meta-analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Association of MDM2 polymorphism with risk and prognosis of leukemia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Profiling Genetic Variation along the Androgen Biosynthesis and Metabolism Pathways Implicates Several Single Nucleotide Polymorphisms and Their Combinations as Prostate Cancer Risk Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

21 January 2018

Identifiers

DOI

10.1002/PROS.23139

1 reference

25 September 2017

1 reference